1200 Participants Needed

Oxygen Levels at Birth for Low Birth Weight Infants

(HiLo Trial)

Recruiting at 15 trial locations
Sv
GS
BK
Overseen ByBarb Kamstra, RN
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Alberta
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine the optimal oxygen level for helping preterm babies, born before 29 weeks, begin breathing immediately after birth. Preterm babies often have underdeveloped lungs and require special care to prevent brain injuries from improper oxygen levels. The trial compares two groups: one receiving 30% oxygen (low concentration) and the other 60% oxygen (high concentration) to identify which leads to better survival and health outcomes. Eligible babies are those born between 23 and 28 weeks of pregnancy, who will receive full resuscitation and have no major congenital issues. As an unphased trial, this study provides a unique opportunity to contribute to crucial research that could enhance care for future preterm infants.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that using higher oxygen levels, such as 60%, for newborns with low birth weight might not be ideal. Some studies have found increased risks, including organ damage and serious brain bleeding, associated with high oxygen use. In certain cases, a nearly fivefold higher risk of death links to higher oxygen levels.

Conversely, starting with lower oxygen levels, like 30%, does not clearly show harm or benefit compared to higher levels. This indicates that experts still lack a definite answer on the best approach.

In summary, while both oxygen levels carry risks and uncertainties, there is insufficient evidence to declare one safer than the other. This trial seeks to determine which level might be better for these tiny, early arrivals.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how different oxygen levels at birth might impact low birth weight infants, which could lead to more tailored care strategies. Traditionally, standard care involves using a set oxygen level, but this study tests whether starting with 30% or 60% oxygen and adjusting based on the baby's needs can improve outcomes. By fine-tuning oxygen delivery in the crucial first minutes of life, the trial aims to optimize oxygen saturation levels, potentially reducing complications and improving long-term health for these vulnerable infants.

What evidence suggests that this trial's treatments could be effective for preterm infants?

This trial will compare the effects of different oxygen levels at birth for low birth weight infants. Research has shown that using 60% oxygen, which participants in the 60% group of this trial will receive, does not significantly change survival rates or other health outcomes compared to lower oxygen levels, such as the 30% oxygen that participants in the 30% group will receive. One study found no difference in survival or major health issues when starting with high oxygen (60%) versus low oxygen (30%) at birth. However, higher oxygen levels have been linked to a greater risk of serious brain bleeding, known as intraventricular hemorrhage (IVH), and in some cases, a much higher risk of death. Oxygen is vital for helping these infants breathe, but finding the right balance is crucial to avoid harm. Therefore, determining the best oxygen level is a key focus to improve survival and health for these vulnerable infants.12567

Who Is on the Research Team?

Georg Schmolzer | IntechOpen

Georg Schmolzer

Principal Investigator

University of Alberta

Are You a Good Fit for This Trial?

This trial is for very low birthweight infants born between 23 and nearly 29 weeks of gestation, who will receive full resuscitation at the study center without major congenital abnormalities. It excludes those not born in this range, with significant birth defects, or who won't get full resuscitation.

Inclusion Criteria

My baby was born between 23 and 29 weeks without major birth defects and received full resuscitation.

Exclusion Criteria

Babies who were not given their first medical care at the study hospital.
My infant was born with a major birth defect.
My baby was born prematurely.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Resuscitation

Infants are resuscitated with either 30% or 60% oxygen concentration for the first 5 minutes after birth, followed by oxygen titration for stability

10 minutes
In-hospital (immediate post-birth)

Neonatal Intensive Care

Infants are monitored and treated in the Neonatal Intensive Care Unit (NICU) for complications and stabilization

Up to 2-3 months

Follow-up

Participants are monitored for neurodevelopmental outcomes and mortality

24 months
Regular follow-up visits

What Are the Treatments Tested in This Trial?

Interventions

  • 30% oxygen group
  • 60% oxygen group
Trial Overview The trial compares two oxygen levels used during resuscitation of premature babies: one group receives 30% oxygen and another gets 60%. Hospitals are randomly chosen to use one level for the first set of infants then switch to the other for a new set.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: 60% groupExperimental Treatment1 Intervention
Group II: 30% groupActive Control1 Intervention

30% oxygen group is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as 30% oxygen for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+

Université de Montréal

Collaborator

Trials
223
Recruited
104,000+

University of Ottawa

Collaborator

Trials
231
Recruited
267,000+

University of British Columbia

Collaborator

Trials
1,506
Recruited
2,528,000+

Memorial University of Newfoundland

Collaborator

Trials
73
Recruited
1,836,000+

University College Cork

Collaborator

Trials
144
Recruited
80,600+

University of Calgary

Collaborator

Trials
827
Recruited
902,000+

Laval University

Collaborator

Trials
439
Recruited
178,000+

Dalhousie University

Collaborator

Trials
177
Recruited
402,000+

University of Toronto

Collaborator

Trials
739
Recruited
1,125,000+

Published Research Related to This Trial

In a study of 12 extremely low birth weight infants over 726 hours, caregivers made frequent manual adjustments to the fraction of inspired oxygen (FiO2), with 851 increases and 1309 decreases, indicating a high variability in oxygen management.
Significant FiO2 adjustments were often linked to medical or nursing procedures, highlighting the challenges in maintaining stable oxygen saturation levels and the potential difficulty in automating these adjustments effectively.
An observational study to quantify manual adjustments of the inspired oxygen fraction in extremely low birth weight infants.van der Eijk, AC., Dankelman, J., Schutte, S., et al.[2022]
Oxygen therapy should start with the minimum effective dose, with initial FiO2 levels ranging from 24% to 100% based on the patient's condition, particularly in cases of COPD exacerbations and chronic hypercapnia.
High FiO2 levels can be safely administered for limited durations, with guidelines suggesting that 100% oxygen is safe for less than six hours, while 70% can be used for up to 24 hours, and 45% should be the upper limit for longer durations to prevent oxygen toxicity.
Oxygen therapy and oxygen toxicity.Tinits, P.[2022]
In a study involving 45 episodes of moderate to severe asthma, administering 35% oxygen was found to be safe and likely sufficient for oxygenation before measuring arterial blood gases.
Using a lower concentration of oxygen could increase the risk of significant hypoxemia in asthma patients, highlighting the importance of starting with 35% oxygen in acute cases.
'Safe oxygen' in acute asthma: prospective trial using 35% Ventimask prior to admission.Ford, DJ., Rothwell, RP.[2019]

Citations

NCT03825835 | 30% or 60% Oxygen at Birth to Improve ...Objectives: To determine whether initial resuscitation of preterm neonates with 60 percent versus 30 percent oxygen results in better neurodevelopmental ...
Does the use of higher versus lower oxygen concentration ...The use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18–24 months in very low birthweight infants?
Optimizing oxygen therapy for preterm infants at birthThe meta-analysis found no difference in mortality or other clinical outcome when resuscitation was initiated with low oxygen (21–30%) or with high oxygen (60– ...
30% or 60% Oxygen at Birth to Improve ...This was associated with increased risk of major intraventricular hemorrhage (IVH), and an almost five times higher risk of death in this ...
Oxygen therapy in premature low birth weight infants is ...Oxygen therapy in premature LBW infants in the neonatal period is associated with higher systolic and diastolic BP levels but has no significant ...
Oxygen Targeting in Extremely Low Birth Weight InfantsThere was no difference in the primary composite outcome (51.6% in the lower vs 49.7% in the higher saturation range). Mortality was 16.6% in ...
Higher versus Lower Oxygen Concentration during ...There is a lack of evidence for either overall benefit or harm in starting resuscitation with either lower (<30%) or higher (>65%) oxygen for ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security